1. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups. (18th May 2018) Authors: Chen‐Liang, T.‐H.; Casado‐Prieto, A. M.; Campos‐Rodríguez, V.; Hurtado, A. M.; Amigo, M. L.; García‐Malo, M. D.; Vicente, V.; Ortuño, F. J.; Jerez, A. Journal: International journal of laboratory hematology Issue: Volume 40:Number 5(2018:Oct.) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1137: ACCURACY AND PROGNOSTIC IMPACT OF FDG PET/CT AND BIOPSY IN BONE MARROW ASSESSMENT OF FOLLICULAR LYMPHOMA AT DIAGNOSIS: A NATION-WIDE STUDY. (23rd June 2022) Authors: Ródenas Quiñonero, I.; Chen-Liang, T.; Martín-Santos, T.; Salar, A.; Fernández-González, M.; Celades, C.; Navarro, J. T.; Martinez, A. B.; Andreu, R.; Balaguer, A.; Martín, A.; Baile, M.; López-Jiménez, J.; Marquet, J.; Teruel, A. I.; Terol, M. J.; Benet, C.; Frutos, L.; Navarro, J. L.; Uña, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB1839: INDEPENDENT PROGNOSTIC VALUE OF A PLATELET COUNT OVER 300X109/L IN ACUTE MYELOBLASTIC LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE REGIMEN. (23rd June 2022) Authors: Ródenas Quiñonero, I.; Jeréz, A.; Ferrer, B.; Orna, E.; Navarro-Ferrando, J. T.; Raya, J. M.; Martin-Santos, T.; Ricard, M.; Bermejo, A.; Morales, R.; Prats, C.; Navarrete, M.; Roldán-Galiacho, V.; Amigo, M. L.; Vicente, V.; Ortuño, F. J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗